Skip to main content

7 Result(s)

within Hugh Watson Remove this filter

and

  1. No Access

    Article

    Risk Factors for Hepatic Hydrothorax in Cirrhosis Patients with Ascites – A Clinical Cohort Study

    The risk factors for hepatic hydrothorax are unknown.

    Thomas Deleuran, Hugh Watson, Hendrik Vilstrup… in Digestive Diseases and Sciences (2022)

  2. Article

    Open Access

    Tender and swollen joint counts are poorly associated with disability in chikungunya arthritis compared to rheumatoid arthritis

    Chronic rheumatological manifestations similar to those of rheumatoid arthritis (RA) are described after chikungunya virus infection. We aimed to compare the relevance of joint counts and symptoms to clinical ...

    Hugh Watson, Ramão Luciano Nogueira-Hayd, Maony Rodrigues-Moreno… in Scientific Reports (2021)

    Download PDF (1078 KB) View Article

  3. No Access

    Article

    Persistent chikungunya arthritis in Roraima, Brazil

    The Amazon region of Brazil experienced a large epidemic of East Central South African (ECSA) chikungunya virus (CHIKV) in 2017 and continuous transmission of CHIKV persists. The impact of chronic arthritis ca...

    Ramão Luciano Nogueira Hayd, Maony Rodrigues Moreno, Felipe Naveca… in Clinical Rheumatology (2020)

  4. No Access

    Article

    Stiffness, pain, and joint counts in chronic chikungunya disease: relevance to disability and quality of life

    To characterize the importance of musculoskeletal stiffness in a cohort of chikungunya patients with chronic joint symptoms.

    Hugh Watson, Sarah R. Tritsch, Liliana Encinales, Andres Cadena… in Clinical Rheumatology (2020)

  5. Article

    Open Access

    Epilepsy as a risk factor for hepatic encephalopathy in patients with cirrhosis: a cohort study

    Epilepsy is associated with an increased mortality among cirrhosis patients, but the reasons are unknown. We aimed to determine whether epilepsy is a risk factor for develo** hepatic encephalopathy (HE), whi...

    Peter Jepsen, Jakob Christensen, Karin Weissenborn, Hugh Watson… in BMC Gastroenterology (2016)

    Download PDF (528 KB) View Article

  6. No Access

    Article

    Satavaptan treatment for ascites in patients with cirrhosis: a meta-analysis of effect on hepatic encephalopathy development

    Satavaptan, a vasopressin V2-receptor antagonist, has been shown to improve hyponatraemia in patients with cirrhosis. Hyponatraemia has been associated with an increased risk of hepatic encephalopathy. The object...

    Hugh Watson, Peter Jepsen, Florence Wong, Pere Ginès… in Metabolic Brain Disease (2013)

  7. No Access

    Article

    Incorporating Affiliates and Contract Research Organizations into Global Clinical Trials

    Globalization of clinical trials, and the complexity surrounding the execution of these trials, has stimulated pharmaceutical companies to review their decision making processes to include input from affiliate...

    S. Michael Harrill, Jane M. Boswick… in Drug information journal : DIJ / Drug Info… (1999)